Clinical Trials

NRG-GI011, A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)

ClinicalTrials.gov Identifier

NCT06958328

Principal Investigator

Neil Newman MD

For more information about this study
View Details

About This Study

NRG-GI011 (LAP100) is a Phase III randomized trial assessing the addition of dose-escalated radiotherapy to chemotherapy in LAPC.